Cetera Investment AdvisersCetera Investment Advisers

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings1,753 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SCHDSCHD
ETF

SCHWAB US DVD EQUITY ETF

2.3M$155M3.1%$20.29-2.13%
8 qtrssince 2020-Q4
Increased
60
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

320,457$114.9M2.3%$378.84-8.19%
16 qtrssince 2018-Q4
Increased
56
1.5M$111.7M2.2%
16 qtrssince 2018-Q4
Increased
54
JPSTJPST
ETF

J P MORGAN EXCHANGE TRADED F

1.5M$76.9M1.5%$41.93+0.03%
13 qtrssince 2019-Q3
Increased
75
VTIVTI
ETF

VANGUARD TOTAL STOCK MARKET VIPERS

399,970$71.8M1.4%$180.01-3.48%
16 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

303,134$70.6M1.4%$208.19+11.10%
16 qtrssince 2018-Q4
Decreased
0
VUGVUG
ETF

VANGUARD GROWTH ETF

305,429$65.3M1.3%$30.12+16.00%
16 qtrssince 2018-Q4
Increased
49
LMBSLMBS
ETF

FIRST TR EXCHANGE-TRADED FD

1.3M$61.4M1.2%$42.24-4.10%
16 qtrssince 2018-Q4
Increased
47
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

166,418$59.4M1.2%$345.21+0.56%
16 qtrssince 2018-Q4
Decreased
0
VTVVTV
ETF

VANGUARD VALUE ETF

478,514$59.1M1.2%$102.56+12.66%
16 qtrssince 2018-Q4
Increased
49
FVDFVD
ETF

FIRST TR EXCHANGE-TRADED FD

1.5M$54.3M1.1%$30.47+10.08%
16 qtrssince 2018-Q4
Increased
47
MUBMUB
ETF

ISHARES NATIONAL MUNI BOND E

486,211$49.9M1.0%$97.18-5.94%
16 qtrssince 2018-Q4
Increased
53
IJHIJH
ETF

ISHARES CORE S&P MIDCAP ETF

203,533$44.6M0.9%$42.20-0.15%
16 qtrssince 2018-Q4
Increased
42
VOOVOO
ETF

VANGUARD S&P 500 ETF

132,960$43.7M0.9%$308.40+3.24%
16 qtrssince 2018-Q4
Increased
48
IJRIJR
ETF

ISHARES CORE S&P SMALL-CAP ETF ETF

474,844$41.4M0.8%$80.14+3.66%
16 qtrssince 2018-Q4
Increased
47
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

415,266$38M0.8%$76.91+0.42%
8 qtrssince 2020-Q4
Increased
46
DGRWDGRW
ETF

WISDOMTREE U.S. QUALITY DIVI

682,052$36.8M0.7%$49.50+2.33%
11 qtrssince 2020-Q1
Increased
45
DGRODGRO
ETF

ISHARES CORE DIVIDEND GROWTH

801,007$35.6M0.7%$39.61+5.34%
16 qtrssince 2018-Q4
Increased
42
BNDBND
ETF

VANGUARD TOTAL BOND MARKET

492,032$35.1M0.7%$72.09-13.90%
16 qtrssince 2018-Q4
Increased
42

ALPHABET INC-CL A

364,311$34.8M0.7%$96.36+0.34%
16 qtrssince 2018-Q4
Increased
66
$5B
AUM
1,753
Positions
Q3 2022
Filing
Rating · 4.0
Quarterly Portfolio Change
+23%Q2'21$6.2B+1%Q3'21$6.3B+11%Q4'21$7B-0%Q1'22$7B-10%Q2'22$6.3B-20%Q3'22$5B
Activity profile
$ moved · Q3'22
New2%Increased58%Decreased37%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.1 years
<1Q4%1-4Q12%1-2Y44%2Y+39%

Cetera Investment Advisers manages $5B across 1753 positions as of Q3 2022. Top holdings: SCHD (3.1%), IVV (2.3%), VANGUARD BD INDEX FDS (2.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q3 2022 Summary

Active quarter - 93 new positions, 169 exits, 692 increased. Top move: JPST (INCREASED, conviction 75). Portfolio: $5.0B across 1753 positions.

Top holdings by portfolio weight

Total AUM$5B
SCHD3.09%
IVV2.29%
VANGUARD BD 2.23%
JPST1.53%
VTI1.43%
MSFT1.41%
VUG1.30%
LMBS1.23%
SPY1.19%
VTV1.18%
Other1.08%

Portfolio allocation by GICS sector

Sectors11
Unknown70.90%
Technology4.84%
Healthcare4.67%
Financial Services3.87%
Consumer Cyclical2.87%
Industrials2.70%
Consumer Defensive2.69%
Communication Services2.53%
Energy1.92%
Real Estate1.55%
Other1.46%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record58
Conviction42
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ABBVABBVABBVIE INC
Q3 2024 Q2 2026+380,469 shares+$144.6M
8Q
LNTLNTALLIANT ENERGY CORP
Q3 2024 Q2 2026+54,323 shares+$7.9M
8Q
ALNYALNYALNYLAM PHARMACEUTICALS INC
Q3 2024 Q2 2026+20,457 shares+$6.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used